Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Guggenheim

BioMarin Pharmaceutical Inc.
Start price
€52.18
25.02.26 / 50%
Target price
€72.96
25.02.27
Performance (%)
-10.89%
Price
€46.50
10.04.26
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -10.89%. This prediction currently runs until 25.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
BioMarin Pharmaceutical Inc. -3.367% -3.367%
iShares Core DAX® 2.554% 0.562%
iShares Nasdaq 100 2.742% -0.599%
iShares Nikkei 225® 6.584% 4.336%
iShares S&P 500 1.930% -0.507%

Comments by Guggenheim for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -10.89%
Target price 72.962
Change
Ends at 25.02.27

BioMarin Pharmaceutical (BMRN) had its price target lowered by Guggenheim from $106.00 to $86.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat

Guggenheim 
0
Report Share
25.02.26

Stopped prediction by Guggenheim for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€52.34
06.08.25
€91.63
06.08.26
-11.16%
10.04.26

Guggenheim 
06.08.25 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€85.26
13.09.23
€102.48
13.09.24
-11.56%
14.09.24

Guggenheim 
13.09.23 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€94.17
28.02.23
€117.80
28.02.24
-13.41%
29.02.24

Guggenheim 
28.02.23 50%